HSPB6 and chronic obstructive pulmonary disease: Previous studies have demonstrated that HSP20 is biophysically screened as a small molecular target for the treatment of chronic obstructive pulmonary disease (COPD), a very common chronic oxidative stress-related airway disease [18].